Concepedia

Blossom Mak

BM

Statistics

Publications

7

Citations

223

H-Index

7

Active since

2020

Affiliations

The University of Sydney(Current)

Chris O’Brien Lifehouse

Garvan Institute of Medical Research

Royal Prince Alfred Hospital

UNSW Sydney

Blossom Mak is an author at The University of Sydney specializing in oncology, biomarkers in genitourinary cancer, and medicine.

ORCID

Publications per year

2020–2023

7

Publications

7

Overcoming enzalutamide resistance in metastatic prostate cancer by targeting sphingosine kinase

Hui‐Ming Lin, Blossom Mak, Nicole Yeung et al. · EBioMedicine · 2021 · 54 citations · Full text

, , +17

Evaluation of a Mainstream Model of Genetic Testing for Men With Prostate Cancer

Tahlia Scheinberg, Annabel Goodwin, Emilia Ip et al. · JCO Oncology Practice · 2020 · 51 citations · Full text

, , +17

Inhibition of guanosine monophosphate synthetase ( <scp>GMPS</scp> ) blocks glutamine metabolism and prostate cancer growth

Qian Wang, Yi Fang Guan, Sarah E. Hancock et al. · The Journal of Pathology · 2021 · 42 citations · Full text

, , +17

Aberrations in circulating ceramide levels are associated with poor clinical outcomes across localised and metastatic prostate cancer

Hui‐Ming Lin, Kevin Huynh, Manish Kohli et al. · Prostate Cancer and Prostatic Diseases · 2021 · 32 citations · Full text

, , +15

Combined impact of lipidomic and genetic aberrations on clinical outcomes in metastatic castration-resistant prostate cancer

Blossom Mak, Hui‐Ming Lin, Edmond M. Kwan et al. · BMC Medicine · 2022 · 21 citations · Full text

, , +17

1–5 of 7